Nephroprotection by SGLT2 Inhibition: Back to the Future?

The introduction of sodium/glucose cotransporter 2 inhibitors (SGLT2i) has opened new perspectives for the management of diabetic population at risk of or with chronic kidney disease (CKD). More important, recent, large real-world studies have repositioned the nephroprotective efficacy of SGLT2i eme...

Full description

Bibliographic Details
Main Authors: Luca De Nicola, Francis B. Gabbai, Carlo Garofalo, Giuseppe Conte, Roberto Minutolo
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/9/7/2243